Women Can Take Antidepressants During Pregnancy

Women Can Take Antidepressants During Pregnancy.
Women who deduce non-fluctuating antidepressants while pregnant do not raise the risk of a stillbirth or death of their baby in the first year of life, according to a colossal new study. The findings stem from an analysis involving 30000 women in Denmark, Finland, Iceland, Norway and Sweden, who gave family to more than 1,6 million babies, in total, between 1996 and 2007. Close to 2 percent of the women took instruction selective serotonin reuptake inhibitors (SSRIs), such as Prozac (fluoxetine) and Paxil (paroxetine), for depressive symptoms during their pregnancy.

The investigating team, led by Dr Olof Stephansson of the Karolinska Institute in Stockholm, Sweden, reports in the Jan 2, 2013 delivery of the Journal of the American Medical Association that initially women taking an SSRI for the dumps did seem to be familiar with statistically higher rates of stillbirth and infant death. However, that uptick in hazard disappeared once they accounted for other factors, including the threat posed by bust and the mother's history of psychiatric disease or hospitalizations, the authors noted in a journal news release.

And "The show study of more than 1,6 million births suggests that SSRI use during pregnancy was not associated with increased risks of stillbirth, neonatal extinction or postneonatal death," Stephansson's team reported. "The increased rates of stillbirth and postneonatal mortality amidst infants exposed to an SSRI during pregnancy were explained by the dangerousness of the underlying maternal psychiatric disease and unfavorable distribution of affectionate characteristics such as cigarette smoking and advanced maternal age," the authors added.

Depression during pregnancy affects between 7 percent and 19 percent of mothers-to-be in economically developed countries, the authors acute out in the report. "Maternal downturn is associated with poorer pregnancy outcomes, including increased peril of preterm delivery, which in turn may cause neonatal morbidity and mortality".

The team acknowledged that use of SSRIs during pregnancy has been associated with start defects, neonatal withdrawal syndrome and pulmonary hypertension of the newborn, which is what led to the on the qui vive study. Although they found that the drugs posed no independent risk regarding stillbirth or infant death, the authors urged mothers and physicians to compare with SSRI use carefully how to make your own licorice. "Decisions respecting use of SSRIs during pregnancy must take into account other perinatal outcomes and the risks associated with maternal barmy illness," Stephansson and colleagues concluded.